Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Change in Cash (2020 - 2025)

Historic Change in Cash for BioScience Health Innovations (BHIC) over the last 6 years, with Q3 2025 value amounting to -$159984.0.

  • BioScience Health Innovations' Change in Cash fell 18451.44% to -$159984.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $806203.0, marking a year-over-year increase of 17682.5%. This contributed to the annual value of $643279.0 for FY2024, which is 828804.28% up from last year.
  • Latest data reveals that BioScience Health Innovations reported Change in Cash of -$159984.0 as of Q3 2025, which was down 18451.44% from $271065.0 recorded in Q2 2025.
  • BioScience Health Innovations' 5-year Change in Cash high stood at $365825.0 for Q1 2025, and its period low was -$159984.0 during Q3 2025.
  • Its 5-year average for Change in Cash is $70058.8, with a median of $12090.0 in 2022.
  • The largest annual percentage gain for BioScience Health Innovations' Change in Cash in the last 5 years was 1638010.38% (2021), contrasted with its biggest fall of 77332.32% (2021).
  • Quarter analysis of 5 years shows BioScience Health Innovations' Change in Cash stood at $94099.0 in 2021, then tumbled by 87.15% to $12090.0 in 2022, then plummeted by 288.17% to -$22750.0 in 2023, then soared by 1547.46% to $329297.0 in 2024, then tumbled by 148.58% to -$159984.0 in 2025.
  • Its Change in Cash was -$159984.0 in Q3 2025, compared to $271065.0 in Q2 2025 and $365825.0 in Q1 2025.